Disease/Infection News

RSS

Population centers in cool, highland regions of East Africa more vulnerable to malaria

Fine-scale climate model projections suggest the possibility that population centers in cool, highland regions of East Africa could be more vulnerable to malaria than previously thought, while population centers in hot, lowland areas could be less vulnerable, according to a team of researchers. The team applied a statistical technique to conventional, coarse-scale climate models to better predict malaria dynamics at local levels.

3 Jul 2014

New meta-analysis highlights significant gaps in hepatitis C care

A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.

3 Jul 2014

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

Building upon their earlier research on the biology of fat metabolism, Joslin scientists discovered that microRNAs -small RNA molecules that play important roles in regulation in many types of tissue - play a major role in the distribution and determination of fat cells and whole body metabolism.

3 Jul 2014

Ralphs Pharmacies continue to offer Tdap vaccinations for whooping cough in Southern California

As the number of pertussis cases, also known as whooping cough, reaches epidemic proportions in California, Ralphs Pharmacies continue to offer Tdap (tetanus, diphtheria, pertussis) vaccinations at its 85 in-store pharmacies throughout Southern California.

2 Jul 2014

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million payment from GlaxoSmithKline related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV).

2 Jul 2014

Clear advances in the fight against tuberculosis are within reach, say immunologists

Leading immunologists expect to see some clear advances in the fight against tuberculosis, an infectious disease that is widespread the world over. Professor Stefan Kaufmann, Director at the Max Planck Institute for Infection Biology in Berlin, echoed these sentiments at today's launch of the scientific programme for the 64th Lindau Nobel Laureate Meeting at Lindau, Germany.

2 Jul 2014

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

AIMM Therapeutics, a leading human therapeutic antibody company, today announced that its partner MedImmune, LLC, the global biologics unit of AstraZeneca, has initiated phase I clinical studies with MEDI8897, a best-in-class antibody for the treatment of respiratory syncytial virus (RSV) infections in young, at risk children.

2 Jul 2014

Lab M launches µPrep Half Fraser Broth ISO (+FAC) for use in isolation of Listeria spp. from food

Lab M has launched µPrep Half Fraser Broth ISO (+FAC), the latest addition to the company’s µPrep range of convenient, ready-to-reconstitute microbiological culture media. Designed for use in the isolation of Listeria spp. from foodstuffs, this complete primary enrichment broth is supplied sterile in a highly robust bag, which simply requires the addition of water.

2 Jul 2014

Fewer deer, less Lyme disease

Since white-tailed deer serve as the primary host for the adult blacklegged tick (Ixodes scapularis) - the vector for Lyme disease - scientists have wondered whether reducing the number of deer in a given area would also mean fewer cases of Lyme disease. Now, after a 13-year study was conducted, researchers in Connecticut have found that reduced deer populations can indeed lead to a reduction in Lyme disease cases.

2 Jul 2014

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival.

2 Jul 2014

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Gateway Apothecary in St. Louis, Mo., has received a Peter M. Fox Excellence in HIV Credentialing Award for 2014. Gateway was the only pharmacy to be recognized among the 17 nationwide award recipients, which consist primarily of physicians and/or medical practices.

1 Jul 2014

Research shows foodborne pathogen can cause disease in some breeds of poultry

Contrary to popular belief, the foodborne pathogen Campylobacter jejuni is not a harmless commensal in chickens but can cause disease in some breeds of poultry according to research published in mBio-, the online open-access journal of the American Society for Microbiology.

1 Jul 2014

Heavy drinkers at greater risk of developing pneumonia and ARDS

Heavy drinking damages the body in many ways. In addition to liver failure, alcoholics are at a much greater risk of developing pneumonia and life threatening acute respiratory distress syndrome (ARDS), for which there is no treatment.

1 Jul 2014

HIV-positive people with early-stage cancer less likely to get cancer treatment

HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.

1 Jul 2014

Malaria parasites alter chemical odor signal of hosts to attract mosquitos

Malaria parasites alter the chemical odor signal of their hosts to attract mosquitos and better spread their offspring, according to researchers, who believe this scent change could be used as a diagnostic tool.

1 Jul 2014

Researchers find unique cell type that can protect against uveitis

Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss.

1 Jul 2014

Study investigates HPV prevalence and screening methods in developing countries

Health screens for cancer-causing infections like HPV can be challenging in developing countries, where residing in rural areas can result in limited access to health services.

1 Jul 2014

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Wheaton Franciscan Healthcare-Iowa is the latest to deploy TRU-D SmartUVC, a 5-foot-5 germ-killing ultraviolet robot equipped with the only infection prevention data collection and reporting software on the market. TRU-D is now in use at Covenant Medical Center in Waterloo and Sartori Medical Center in Cedar Falls, Iowa.

30 Jun 2014

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)

30 Jun 2014

Sedia Biosciences to present results of HIV incidence assay at International AIDS Conference

Sedia Biosciences Corporation of Portland, Oregon will be presenting its first public results of a new rapid point-of-care HIV incidence assay at the upcoming 20th International AIDS Conference in Melbourne, Australia, July 21-25, 2014.

30 Jun 2014

Disease/Infection News

Population centers in cool, highland regions of East Africa more vulnerable to malaria

New meta-analysis highlights significant gaps in hepatitis C care

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

Ralphs Pharmacies continue to offer Tdap vaccinations for whooping cough in Southern California

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Clear advances in the fight against tuberculosis are within reach, say immunologists

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

Lab M launches µPrep Half Fraser Broth ISO (+FAC) for use in isolation of Listeria spp. from food

Fewer deer, less Lyme disease

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Research shows foodborne pathogen can cause disease in some breeds of poultry

Heavy drinkers at greater risk of developing pneumonia and ARDS

HIV-positive people with early-stage cancer less likely to get cancer treatment

Malaria parasites alter chemical odor signal of hosts to attract mosquitos

Researchers find unique cell type that can protect against uveitis

Study investigates HPV prevalence and screening methods in developing countries

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Sedia Biosciences to present results of HIV incidence assay at International AIDS Conference

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News